10+ Year Rx-360 Member Reaches Audit Milestone

July 25, 2022

  The Rx-360 Credit Program is a members-only benefit that GSK has found to be tremendously valuable, as it has generated nearly $100,000 in credits for the science-led global healthcare company. “Not only does Rx-360 […]

Episode 5: Interview with Best-Selling Author Katherine Eban

July 14, 2022

Host Jim Fries speaks to Katherine Eban, contributing editor for Vanity Fair and a New York Times best-selling author, in the fifth episode of The Patient Safety Podcast. Eban walks Fries through her investigation into […]

Rx-360 Insights

Episode 4: Interview with Leigh Verbois, Director of the Office of Drug Security, Integrity and Response for the FDA

June 7, 2022

Host Jim Fries speaks to Leigh Verbois, the Director of the Office of Drug Security, Integrity, and Response for the FDA, in the fourth episode of The Patient Safety Podcast. The episode covers Verbois’ time […]

Publications

Human Blood Origin Materials for Cell & Gene Therapy Manufacturing Supplier Questionnaire

May 24, 2022

Materials derived from human blood such as human serum albumin and transferrin are frequently used either as components of cell culture medium or in other processes. Suppliers of such reagents have incorporated multiple mitigation steps such as sourcing pharmaceutical grade or licensed drug product, sourcing from safe geographical regions, testing for contaminants and inactivation. In addition, this information needs to be available for review during inspections and in regulatory filings. This questionnaire is a comprehensive list of those requirements and will be a useful document for reference.

Rx-360 Patient Safety Podcast: Interview with USP CEO Ron Piervincenzi, Ph.D.

April 12, 2022

Rx-360 released the third episode of The Patient Safety Podcast, featuring Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP).

Episode 3: Interview with Ron Piervincenzi, CEO of The United States Pharmacopeia

April 7, 2022

Host Jim Fries speaks to Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP), in the third episode of The Patient Safety Podcast. The episode covers topics such as Piervincenzi’s time at USP, the […]

Episode 2: Interview with Dr. Janet Woodcock, Principal Deputy Commissioner of the FDA

March 1, 2022

For the second episode of the Patient Safety Podcast, host Jim Fries, CEO of Rx-360, speaks to Dr. Janet Woodcock, Principal Deputy Commissioner of the Food and Drug Administration. Throughout the course of their conversation, […]

Rx-360 Launches New Podcast: The Patient Safety Podcast

January 19, 2022

Rx-360 has released the first episode of The Patient Safety Podcast, a new series that explores patient safety in the pharmaceutical ecosystem.

Rx-360 Insights

Episode 1: Interview with Martin Van Trieste, CEO of Civica Rx

January 17, 2022

Host Jim Fries, CEO of Rx-360, speaks to Martin Van Trieste, president and CEO of Civica Rx in the first episode of the Patient Safety Podcast. Covering topics such as the origin story of Rx-360 […]

Rx-360 Insights: Member & Organization Updates

Rx-360 Announces 2022 Board of Directors

December 29, 2021

Rx-360 is pleased to announce their 2022 Board of Directors.